A 10-Year Follow-up to Determine the Effect of YAG Laser Iridotomy on the Natural History of Pigment Dispersion Syndrome A Randomized Clinical Trial
|
|
- Hillary Dalton
- 6 years ago
- Views:
Transcription
1 Research Original Investigation A 10-Year Follow-up to Determine the Effect of YAG Laser Iridotomy on the Natural History of Pigment Dispersion Syndrome A Randomized Clinical Trial Stefano A. Gandolfi, MD; Nicola Ungaro, MD; Maria Grazia Tardini, AO; Stella Ghirardini, AO; Arturo Carta, MD; Paolo Mora, MD IMPORTANCE Prospective long-term analyses of the role of drug-induced mydriasis and laser peripheral iridotomy (LPI) are needed to identify and manage the eyes of patients with pigment dispersion syndrome (PDS) at risk for progressing to ocular hypertension. CME Quiz at jamanetworkcme.com and CME Questions page 1496 OBJECTIVE To assess the 10-year incidence of increased intraocular pressure (IOP) in the 2 eyes of patients with PDS, with 1 eye that underwent LPI and the other that did not. DESIGN, SETTING, AND PARTICIPANTS In a randomized clinical trial in the glaucoma research unit at the University Hospital of Parma, Italy, 72 patients with PDS underwent phenylephrine testing. Of these 72 patients, 29 (58 eyes) tested positive for succeeding IOP elevation, and 43 (59 eyes) tested negative. For the 29 high-risk patients (all in both eyes), one eye was randomly assigned to LPI, and the fellow eye was left untreated. For the 43 low-risk patients, the affected eyes were left untreated. MAIN OUTCOMES AND MEASURES An IOP elevation of 5 mm Hg or higher vs baseline (daily phasing) was considered to be a significant increase (ie, an event). RESULTS In the high-risk group, 3 of 21 eyes that underwent LPI (14.3%) and 13 of 21 untreated eyes (61.9%) showed an increase in IOP of 5 mm Hg or higher during the follow-up period; 4 of 35 low-risk eyes (11.4%) showed a similar increase. Event-free mean (SD) time was 7.99 (0.43) years for high-risk treated eyes, 3.89 (0.68) years for high-risk untreated eyes, and 7.16 (0.23) years for low-risk eyes. The log-rank test showed the following: P <.001 for treated high-risk eyes vs untreated high-risk eyes, P =.74 for treated high-risk eyes vs low-risk eyes, and P <.001 for untreated high-risk eyes vs low-risk eyes. CONCLUSIONS AND RELEVANCE At the end of the 10-year follow-up, (1) approximately one-third of the whole PDS patient population showed an IOP increase of 5 mm Hg or higher in at least 1 eye; (2) phenylephrine testing identified eyes at high risk for developing IOP elevation; and (3) LPI, when performed on high-risk eyes, reduced the rate of IOP elevation to the same level as the low-risk eyes. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT JAMA Ophthalmol. 2014;132(12): doi: /jamaophthalmol Published online September 4, Author Affiliations: Ophthalmology Unit, Department of Biological, Biotechnological, and Translational Sciences, University of Parma, Parma, Italy. Corresponding Author: Stefano A. Gandolfi, MD, Ophthalmology Unit, Department of Biological, Biotechnological, and Translational Sciences, University of Parma, via Gramsci 14, Parma, Italy (stefano.gandolfi@unipr.it). 1433
2 Research Original Investigation Laser Iridotomy and Pigment Dispersion Syndrome Eyes affected by pigment dispersion syndrome (PDS) typically show midperipheral, slitlike iris pigment epithelial defects, deposition of pigment granules on the anterior segment structures of the eye, and a floppy iris root, often (but not always) assuming a concave configuration. Liberation of pigment occurs after repeated contact of the posterior iris surface of a concave iris with the lens zonules and anterior lens capsule. In the long run, the overload of pigment affects the trabecular meshwork, leading to a progressive increase in intraocular pressure (IOP), followed by the occurrence of glaucomatous damage to the optic nerve (pigmentary glaucoma [PG]). 1 The backward movement of the iris root (the so-called reverse pupillary block) is an accepted mechanism for pigment dispersion. 2 This seems to be triggered by blinking, accommodation, and pupillary dilation, and it is more likely to occur in eyes showing a concave iris root. 3,4 Campbell 2 hypothesized that an iridotomy could be beneficial in eyes showing a reverse pupillary block, slowing the rate of progression from PDS to PG. A flattening of the concave iris root, with an eventual decreased iridolenticular contact, was in fact described after Nd:YAG laser peripheral iridotomy (LPI) was performed on eyes with PDS or PG. 5,6 The aim of our study was to determine the 10-year benefit of Nd:YAG LPI in reducing the incidence of significant IOP elevation in PDS eyes considered at high risk for progression to PG. A 2-year interim analysis was published previously. 7 Methods Our study was conducted in the glaucoma research unit at the University Hospital of Parma (Italy). The protocol was approved by the ethics committee of the hospital, and written informed consent was obtained according to the tenets of the Declaration of Helsinki. Participants were not financially compensated. Background From 1990 to 1991, 1154 workers in the Parma area were screened for fitness for long-term use of a video monitor; 86 were referred to the glaucoma research unit for suspected PDS. The diagnosis was confirmed for 72 participants (117 eyes), based on the following criteria: Deposition of pigment on the corneal endothelium (Krukenberg spindle); At least 1 midperipheral, slitlike iris defect detected by transillumination with a slitlamp; Deposition of brownish pigment on the angle structures for 270 or more; An IOP of less than 18 mm Hg; Absence of pseudoexfoliative material on the anterior lens capsule (full mydriasis) and on the pupillary border; and Absence of glaucomatous visual field defect. 8 Patient Selection and Randomization for Treatment A phenylephrine provocative test was performed on the affected eyes of all patients with PDS. The test was performed by instilling 1 drop of phenylephrine hydrochloride, 10%, 3 times every 5 minutes. The liberation of pigment was graded with a slitlamp according to the modification of the Mitsui and Takagi 9 scale by Epstein et al. 10 The test result was positive if at least 10 particles were detected in a single light beam (ie, the lowest grade on a 1-4 scale in Epstein et al, 10 corresponding to grade 3 on a 0-6 scale in Mitsui and Takagi 9 ). For safety reasons, IOP was checked 60 and 120 minutes after instillation of the mydriatic agent. Patients who had a positive phenylephrine test result were considered to be at high risk for succeeding IOP decompensation. 11,12 Patients who had a negative phenylephrine test result were then considered to be at low risk. No patient had one eye that was at high risk and the other that was at low risk. Gonioscopy was performed to evaluate the iris root in each eye. In brief, gonioscopy was performed by the same investigator (S.A.G.), and the iris root was evaluated in both basal conditions and by accommodation. Accommodation was elicited by asking the patient to fixate with the fellow eye on a nearby target (ie, the number on the slitlamp enlargement rotary). The iris root was qualified as concave when assuming a concave configuration in either condition (basal or by accommodation). The iris root configuration was confirmed by ultrasound biomicroscopy analysis, which was performed during follow-up, when this technology became available in our clinic (since 2002). 13 High-risk patients were asked to participate in the active part of the study, a randomized clinical trial of the efficacy of laser iridotomy. When both eyes of a high-risk patient were eligible for treatment, one eye was randomly assigned (using a biased coin method on a computerized system) to undergo Nd:YAG LPI, and the fellow eye was left untreated as a control. Nd:YAG LPI was performed according to a procedure described previously. 7 Low-risk patients were left untreated as a control, contributing further to the natural history part of the study. To avoid potential statistical bias (in particular, the possible correlation between a person s right and left eyes), for low-risk patients with bilateral involvement, only one eye (the right eye) was arbitrarily considered for our study. For high-risk patients, the application of a pure mechanical treatment such as Nd:YAG LPI for one eye was unable to influence the clinical course of the fellow eye or, at worst, was responsible for an underestimation of P values and confidence intervals. 14 Once qualified for followup, patients were regularly checked every 6 months (±1 month). Examination Procedure The IOP, best-corrected visual acuity, lens transparency, optic nerve head, and visual field were assessed at baseline and at every follow-up visit. Examination procedures have been partly described in a previous study. 7 A more detailed description is hereby reported. The main outcome measure was IOP. Daily phasing (6 readings, from 8:00 AM to 6:00 PM) was performed at every planned follow-up visit. Intraocular pressure was measured by 2 masked investigators (one rotating the dial and the other reading the value on the dial). Masking was achieved by performing tonometry before the slitlamp examination. Two readings were performed. In the case of a difference of more than 2 mm Hg between the readings, a third reading was obtained, and the 2 closest values were averaged. Having 6 indepen JAMA Ophthalmology December 2014 Volume 132, Number 12 jamaophthalmology.com
3 Laser Iridotomy and Pigment Dispersion Syndrome Original Investigation Research Table. Demographic Characteristics of the 2 Groups Characteristic High-Risk Group (n = 21) Low-Risk Group (n = 35) P Value Male sex, No. (%) 14 (67) 23 (66) >.10 Age, mean (range), y 34 (19-60) 31 (21-52) >.10 Refraction (spherical equivalent), D 3.1 (1.5) 2.5 (2.5) >.10 IOP, mean (SD), mm Hg Treated eyes 14.3 (2.3) 15.0 (1.9) Untreated eyes 13.9 (2.2) NA >.10 BCVA, mean (SD), logmar 0.06 (0.08) 0.04 (0.10) Snellen equivalent 20/20 (20/25) 20/20 (20/25) >.10 Abbreviations: BCVA, best-corrected visual acuity; D, diopters; IOP, intraocular pressure; NA, not applicable. dent values for each daily phasing, we considered the IOP representative of that phasing of the average of the 2 highest values. 7 Calibration of the tonometer was performed routinely, according to the standardized operating procedure of the Clinical Trial Site of the European Vision Institute (http: // /article/european-vision-institute-clinical-trials-sites-ofexcellence.html). Best-corrected visual acuity was a safety outcome measure. Patients were asked to read the Early Treatment Diabetic Retinopathy chart, placed at a distance of 4 m, until no more letters could be identified correctly. The letters properly identified were then counted, and the corresponding log- MAR was recorded. Lens transparency was a safety outcome measure. The state of the lens was assessed in full mydriasis with a slitlamp by 2 masked investigators (S.A.G. and N.U.) referring to the Lens Opacity Classification System II. The optic nerve head was a safety outcome measure. The optic nerve head was observed regularly with a slitlamp in full mydriasis, in the framework of a complete examination of the posterior pole and the peripheral retina. The visual field was a safety outcome. A visual field examination was performed using computer-assisted static perimetry. The Octopus program GI (Interzeag) was used for the first 3 years of follow-up, and then a Humphrey 24-2 SITA (Swedish Interactive Thresholding Algorithm) standard program (Carl Zeiss Meditec) was used for the remainder of follow-ups. Statistical Methods and Data Analysis As reported in the interim analysis, 7 the occurrence of an increase in IOP of 5 mm Hg or higher with respect to the baseline visit was adopted for the definition of a significant increase in IOP, and it was considered to be the event that the study was tailored to detect. This definition is consistent with that suggested by Epstein et al 10 for properly defining pigmentary glaucoma suspects (ie, patients with PDS who have an IOP of mm Hg). The trial was designed to detect differences in the event (1) between high-risk eyes that had undergone Nd:YAG LPI and untreated high-risk control eyes (the interventional arm), and (2) between low-risk control eyes and untreated high-risk control eyes (the observational arm). The sample size was adequate to allow detection of a 45% difference in the event rate either between treated and untreated high-risk eyes or between high- and low-risk eyes (type I error: α =.05, 95% power). Between groups, the mean value differences in normally distributed parameters were analyzed using the t test. Proportions were compared using the Fisher exact test. Statistical significance was set at P <.01. For the follow-up analysis, Kaplan- Meier plots were prepared for each group of patients (ie, patients with treated and untreated high-risk eyes and patients with low-risk eyes) and compared using the log-rank test (XLSTAT software). Results In total, 29 patients with PDS had a positive phenylephrine test result (ie, 58 high-risk eyes, all bilateral), and 43 patients with PDS had a negative phenylephrine test result (ie, 16 low-risk patients with PDS in both eyes and 27 low-risk patients with PDS in 1 eye). Of the 59 low-risk eyes, only 43 (1 eye for each patient) were considered for the study. The demographics of the high- and low-risk groups are detailed in the Table. No significant difference was found for any parameter. All 58 highrisk eyes were assessed and had a concave iris root. Four of the 43 low-risk eyes had a concave iris root. Two of the 58 high-risk eyes and 1 of the 59 low-risk eyes showed an increase in IOP of higher than 2 mm Hg 1 hour after the phenylephrine test. This was consistent with what was stated in a previous study. 10 Nd:YAG LPI was performed on 1 eye (randomly assigned) of each of the 26 high-risk patients who agreed to have the procedure (3 of the 29 patients refused). Of these 26 patients, only 21 (42 eyes) were followed up (because 4 requested immediate laser treatment in the fellow eye and 1 died before the baseline visit). In the low-risk group, 8 patients dropped out of the study. Thus, 35 low-risk patients (35 eyes) were qualified for follow-up (Figure 1). Sixteen high-risk patients (32 eyes) and 30 low-risk patients (30 eyes) completed the 10-year followup. Ten patients (5 high-risk patients and 5 low-risk patients) were lost to follow-up. None of these patients lost to follow-up had shown an IOP elevation of 5 mm Hg or higher before they dropped out of the study. In the high-risk group, 3 of 21 eyes that had undergone Nd:YAG LPI (14.3%) and 13 of 21 untreated eyes (61.9%) had shownaniopelevationof5mmhgorhigher.the3patients who had undergone Nd:YAG LPI and had shown an IOP elevation of 5 mm Hg or higher also experienced a conversion from jamaophthalmology.com JAMA Ophthalmology December 2014 Volume 132, Number
4 Research Original Investigation Laser Iridotomy and Pigment Dispersion Syndrome Figure 1. Patient Flowchart 86 Patients assessed for eligibility 14 Excluded for not having PDS 72 With PDS enrolled 29 High-risk patients with PDS in both eyes (58 eyes) 43 Low-risk patients 16 With PDS in both eyes (but only 16 eyes studied) 27 With PDS in 1 eye (27 eyes) 52 Eyes randomized 26 Randomized to undergo Nd:YAG LPI 26 Randomized to no treatment 43 Eyes not treated 5 Patients lost to 30-mo follow-up 1 Died 4 Dropped out 5 Patients lost to 30-mo follow-up 21 High-risk patients qualified for follow-up (42 eyes) 35 Low-risk patients qualified for follow-up (35 eyes) 5 Patients lost to follow-up (10 eyes) 5 Patients lost to follow-up (5 eyes) 16 Eyes underwent Nd:YAG LPI (3 events) 16 Eyes did not undergo treatment (13 events) 30 Eyes contributed to the natural history part of the study (4 events) An increase in intraocular pressure (IOP) of 5 mm Hg or higher with respect to the baseline visit was adopted for the definition of a significant increase in IOP, and it was considered to be the event that the study was tailored to detect. LPI indicates laser peripheral iridotomy; PDS, pigment dispersion syndrome. PDS to PG in the untreated fellow eye. In the low-risk group, 4 of 35 eyes (one with a concave iris root) had shown an IOP elevation of 5 mm Hg or higher (11.4%). The overall 10-year event rate for eyes that had not undergone Nd:YAG LPI (ie, untreated high- and low-risk eyes) was 30.4%. All these converting eyes showed an iridocorneal angle in near vision of greater than 53 when tested by ultrasound biomicroscopy during follow-up. 13 Statistical analysis showed that the mean (SD) survival time (ie, the mean time during which the eyes were event-free) was 7.99 (0.43) years for the treated high-risk eyes, 3.89 (0.68) years for the untreated high-risk eyes, and 7.16 (0.23) years for the low-risk eyes. The log-rank test showed the following: P <.001 for treated high-risk eyes vs untreated highrisk eyes, P =.74 for treated high-risk eyes vs low-risk eyes, and P <.001 for untreated high-risk eyes vs low-risk eyes (Figure 2). No significant difference in age was found between any patients who experienced an event (mean [SD] age, 29 [7] years) and any event-free patients (33 [10] years) (P =.15). However, when the age analysis was performed within the 2 groups (ie, the high- and low-risk groups), we found that, in the highrisk group, the 13 patients who experienced an event were significantly younger than the 16 event-free patients (27 [6] years vs 41 [12] years; P =.002); in the low-risk group, the mean age was statistically comparable between patients who experienced an event and event-free patients. Two eyes included in the treated high-risk group and 2 eyes included in the untreated high-risk group became worse (by at least 1 step in the Lens Opacity Classification System II for cataracts). On occurrence of the event, the 3 eyes in the treated high-risk group underwent argon laser trabeculoplasty; in 2 of these eyes, latanoprost, 0.005%, every day was also prescribed to reach the estimated target IOP. The 13 eyes that had shown an IOP elevation of 5 mm Hg or higher (ie, the event) in the untreated high-risk group were treated as follows: Nd:YAG LPI (100% of eyes), argon laser trabeculoplasty (6 eyes), and topical hypotensive drugs (10 eyes). The 4 low-risk eyes that had shown an IOP elevation of 5 mm Hg or higher were treated as follows: Nd:YAG LPI (the 1 eye showing a concave iris root), argon laser trabeculoplasty (4 eyes), and additional topical hypotensive drugs (1 eye). No eye showed visual field progression (defined as a point being flagged at P <.05 in the corrected pattern standard deviation or having glaucoma hemifield test results outside normal limits) during follow-up. Discussion The data collected from the study cohorts during the 10-year follow-up provide the following evidence: (1) approximately 1436 JAMA Ophthalmology December 2014 Volume 132, Number 12 jamaophthalmology.com
5 Laser Iridotomy and Pigment Dispersion Syndrome Original Investigation Research one-thirdofallpatientswithpdsshowedanincreaseiniop of 5 mm Hg or higher in at least 1 eye; (2) dispersion of pigment after drug-induced mydriasis could support the identification of those PDS eyes at high risk for elevated IOP; and (3) Nd:YAG LPI, when performed on high-risk eyes, reduced the rate of IOP elevation to the same level as the low-risk eyes. If we assume that the development of ocular hypertension in PDS eyes is the first step in the continuum to PG, 15 our data can be interpreted within the framework of the possible prevention of, or delay in, the conversion from PDS to PG. The actual rate of conversion from PDS to PG is still a matter of debate. Migliazzo et al 11 described 35% of patients with PDS and ocular hypertension developing disc and field changes over a mean follow-up of 17.3 years. Farrar et al, 8 while following a group of patients affected by PDS or PG, showed a 50% conversion rate over a mean follow-up of 4.3 years. In a retrospective community-based study, 16 the probability of converting from PDS to PG was 10% at 5 years and 15% at 15 years. More recently, Scott et al 17 reported that 17% of eyes with PDS and a mean basal IOP of 23.7 mm Hg were started on medical treatment during a 3-year followup. Because of the heterogeneity of the definitions of conversion that have been adopted to date, it is almost impossible to compare our results with the data already mentioned. However, a tentative summary is shown in Figure 3. 8,11,16-18 Determining which eye affected by PDS will eventually develop PG can be difficult. Active pigment dispersion (ie, the detection over time of an increased amount of pigment deposition on anterior segment structures) seems to be a major risk factor for conversion. 18,19 Interestingly, Küchle and coworkers observed melanin granules in the anterior chamber of patients with PDS, the density being increased by pupillary dilatation. 20,21 However, as suggested by Schenker et al, a pupillary movement, and the induced mechanical abrasion of pigment epithelium, while necessary to induce liberation of pigment, are not always sufficient to do so. 22(p599) Concurrent abnormalities of the iris, as well as comorbidities and genetic factors, must play a role in facilitating the loss of pigment from the posterior iris surface. 5,23 In our study, 58 of 117 PDS eyes had a positive phenylephrine test result. When left untreated, more than 60% of these eyes showed an increase in IOP of 5 mm Hg or higher during the 10-year follow-up. Conversely, around 10% of those eyes that had a negative phenylephrine test result also had the same increase in IOP. We can then assume that the test was able to separate those eyes showing a relatively unstable iris pigment epithelium, leading to active pigment dispersion and to the eventual development of ocular hypertension. Otherwise, the positive predictive value of such a test is not absolute, considering that 4 of 35 low-risk eyes showed an increase in IOP of 5 mm Hg or higher and that 8 of 21 untreated high-risk eyes did not develop ocular hypertension over the course of the whole follow-up period. For the high-risk group, at the end of our follow-up, patients who showed an increase in IOP of 5 mm Hg or higher were significantly younger than event-free patients. This result confirms our 2-year ad interim analysis, which showed that the Figure 2. Kaplan-Meier Plots (Cumulative Survival Function) for Each Group Proportion of Patients Without Event High-risk patients who underwent Nd:YAG LPI High-risk controls Low-risk patients Time, y LPI indicates laser peripheral iridotomy. Figure 3. Rate of Conversion From Pigment Dispersion Syndrome to Pigmentary Glaucoma in the Literature Conversion Rate, % Richter et al 18 Farrar et al 8 Scott et al 17 Present study Siddiqui et al 16 Migliazzo et al Time, y difference in IOP between the treated eyes and the untreated fellow eyes correlated inversely with age. Owing to the small number of patients involved, however, this result is too underpowered for any possible further inference. While studying the occurrence of pigment liberation in PDS, Küchle et al 24 found that Nd:YAG LPI resulted in a significant decrease in aqueous melanin granules in eyes with PDS in both basal conditions and on dilatation. A lower amount of pigment liberation can eventually lead to a decreased risk of impairment of a vital and still-functioning trabecular meshwork with a lower incidence of ocular hypertension. 19 Interestingly, iridotomy did not offer any benefit when performed on PDS eyes showing an already increased IOP or on eyes affected by PG. 17,25 This is not surprising; as already stated, Nd: YAG LPI is only expected to prevent pigment liberation in the anterior chamber. If the trabecular meshwork is still functioning, Nd:YAG LPI will stop pigment from damaging it, thereby preventing ocular hypertension. If ocular hypertension has already occurred, the trabecular meshwork can be assumed to already be damaged. Thus, Nd:YAG LPI will be less effective or not effective with respect to IOP in the long term. jamaophthalmology.com JAMA Ophthalmology December 2014 Volume 132, Number
6 Research Original Investigation Laser Iridotomy and Pigment Dispersion Syndrome In addition, Nd:YAG LPI, by restoring the normal iris configuration, is expected to be effective in PDS eyes showing a concave iris root. This was the case in no more than half of the patient population in the study by Scott et al. 17 Meanwhile, no data on iris root configuration were reported in a retrospective study on PG. 25 In the present study, PDS eyes showing both a peak IOP of less than 18 mm Hg and a concave iris root were randomly assigned to Nd:YAG LPI. These stringent criteria may explain the positive outcome of this trial. Conclusions In conclusion, our 10-year follow-up study suggests that drug-induced mydriasis can help in identifying PDS eyes at risk for progressing to ocular hypertension. Nd:YAG LPI, when performed at the appropriate time and on high-risk eyes showing a concave iris root, can be protective over the long term. ARTICLE INFORMATION Submitted for Publication: February 8, 2014; final revision received April 22, 2014; accepted May 21, Published Online: September 4, doi: /jamaophthalmol Author Contributions: Dr Gandolfi had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Gandolfi, Carta. Acquisition, analysis, or interpretation of data: Gandolfi, Ungaro, Tardini, Ghirardini, Mora. Drafting of the manuscript: Gandolfi, Tardini, Ghirardini, Carta, Mora. Critical revision of the manuscript for important intellectual content: Gandolfi, Ungaro. Statistical analysis: Ghirardini, Carta, Mora. Obtained funding: Gandolfi. Administrative, technical, or material support: Ungaro, Tardini. Study supervision: Gandolfi, Ungaro, Mora. Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. REFERENCES 1. Gandolfi SA, Ungaro N, Mora P, Sangermani C. Pigmentary glaucoma. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, et al. Glaucoma: Medical Diagnosis and Therapy. Philadelphia, PA: Elsevier-Saunders; 2009: Campbell DG. Pigmentary dispersion and glaucoma. A new theory. Arch Ophthalmol. 1979;97 (9): Karickhoff JR. Reverse pupillary block in pigmentary glaucoma: follow up and new developments.ophthalmic Surg. 1993;24(8): Pavlin CJ, Harasiewicz K, Foster FS. Posterior iris bowing in pigmentary dispersion syndrome caused by accommodation. Am J Ophthalmol. 1994;118(1): Carassa RG, Bettin P, Fiori M, Brancato R. Nd:YAG laser iridotomy in pigment dispersion syndrome: an ultrasound biomicroscopic study. Br J Ophthalmol. 1998;82(2): Breingan PJ, Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Ritch R. Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol. 1999;117 (3): Gandolfi SA, Vecchi M. Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome. Ophthalmology. 1996;103 (10): Farrar SM, Shields MB, Miller KN, Stoup CM. Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome. Am J Ophthalmol. 1989;108(3): Mitsui Y, Takagi Y. Nature of aqueous floaters due to sympathomimetic mydriasis. Arch Ophthalmol. 1961;65: Epstein DL, Boger WP III, Grant WM. Phenylephrine provocative testing in pigment dispersion syndrome. Am J Ophthalmology. 1978; 85(1): Migliazzo CV, Shaffer RN, Nykin R, Magee S. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1986;93(12): Farrar SM, Shields MB. Current concepts in pigmentary glaucoma. Surv Ophthalmol. 1993;37 (4): Mora P, Sangermani C, Ghirardini S, Carta A, Ungaro N, Gandolfi S. Ultrasound biomicroscopy and iris pigment dispersion: a case-control study. Br J Ophthalmol. 2010;94(4): Glynn RJ, Rosner B. Regression methods when the eye is the unit of analysis. Ophthalmic Epidemiol. 2012;19(3): Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma a major review. Clin Experiment Ophthalmol. 2008; 36(9): Siddiqui Y, Ten Hulzen RD, Cameron JD, Hodge DO, Johnson DH. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135(6): Scott A, Kotecha A, Bunce C, et al. YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial. Ophthalmology. 2011;118(3): Richter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma: a prospective study of the natural history. Arch Ophthalmol. 1986;104(2): Campbell DG, Schertzer RM. Pathophysiology of pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol. 1995;6(2): Küchle M, Mardin CY, Nguyen NX, Martus P, Naumann GO. Quantification of aqueous melanin granules in primary pigment dispersion syndrome. Am J Ophthalmol. 1998;126(3): Mardin CY, Küchle M, Nguyen NX, Martus P, Naumann GO. Quantification of aqueous melanin granules, intraocular pressure and glaucomatous damage in primary pigment dispersion syndrome. Ophthalmology. 2000;107(3): Schenker HI, Luntz MH, Kels B, Podos SM. Exercise-induced increase of intraocular pressure in the pigmentary dispersion syndrome. Am J Ophthalmol. 1980;89(4): Lascaratos G, Shah A, Garway-Heath DF. The genetics of pigment dispersion syndrome and pigmentary glaucoma. Surv Ophthalmol. 2013;58 (2): Küchle M, Nguyen NX, Mardin CY, Naumann GO. Effect of neodymium:yag laser iridotomy on number of aqueous melanin granules in primary pigment dispersion syndrome. Graefes Arch Clin Exp Ophthalmol. 2001;239(6): Reistad CE, Shields MB, Campbell DG, Ritch R, Wang JC, Wand M; American Glaucoma Society Pigmentary Glaucoma Iridotomy Study Group. The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma. J Glaucoma. 2005;14(4): JAMA Ophthalmology December 2014 Volume 132, Number 12 jamaophthalmology.com
Srishti Raj, Gunjan Joshi, Manpreet Kaur, Faisal Thattaruthody, Sushmita Kaushik, Surinder S. Pandav
Clinical and Experimental Vision and Eye Research (2018), 1, 16 20 ORIGINAL ARTICLE Role of laser peripheral iridotomy and treatment outcomes in patients of pigment dispersion syndrome, pigmentary ocular
More informationThe evaluation of retinal nerve fiber layer in pigment dispersion syndrome and pigmentary glaucoma using scanning laser polarimetry
European Journal of Ophthalmology / Vol. 13 no. 4, 2003 / pp. 377-382 The evaluation of retinal nerve fiber layer in pigment dispersion syndrome and pigmentary glaucoma using scanning laser polarimetry
More informationEffect of brimonidine on intraocular pressure in normal tension glaucoma: A short term clinical trial
European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 611-615 Effect of brimonidine on intraocular pressure in normal tension glaucoma: A short term clinical trial S.A. GANDOLFI, L. CIMINO, P.
More informationUnderstanding Angle Closure
Case Understanding Angle Closure Dominick L. Opitz, OD, FAAO Associate Professor Illinois College of Optometry 56 year old Caucasian Male Primary Eye Exam BCVA: 20/25 OD with+1.25 DS 20/25 OS with +1.75
More informationJOURNAL OF OPHTHALMOLOGY AND RELATED SCIENCES
JOURNAL OF OPHTHALMOLOGY AND RELATED SCIENCES BILATERAL ACUTE TRANSILLUMINATION OF THE IRIS Kavitha Avadhani 1, MD, MS, Jay Kalliath 1, MS, FRCS 1 Department of Ophthalmology, NMC Speciality Hospital,
More informationGlaucoma: Diagnostic Modalities
Glaucoma: Diagnostic Modalities - Dr. Barun Kumar Nayak, Dr. Sarika Ramugade Glaucoma is a leading cause of blindness in the world, especially in older people. Early detection and treatment by ophthalmologist
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular
More informationPREVALENCE OF GLAUCOMA AMONG FISHERMEN COMMUNITY OF MUNDRA TALUKA OF KUTCH DISTRICT- A CROSS- SECTIONAL STUDY
ORIGINAL RESEARCH PREVALENCE OF GLAUCOMA AMONG FISHERMEN COMMUNITY OF MUNDRA TALUKA OF KUTCH DISTRICT- A CROSS- SECTIONAL STUDY Sanjay Upadhyay 1, Jayantilal Shah 2 1 Assistant Professor, 2 Associate Professor,
More informationThe Effect of Pupil Dilation on Scanning Laser Polarimetry With Variable Corneal Compensation
C L I N I C A L S C I E N C E The Effect of Pupil Dilation on Scanning Laser Polarimetry With Variable Corneal Compensation Amjad Horani, MD; Shahar Frenkel, MD, PhD; Eytan Z. Blumenthal, MD BACKGROUND
More informationRomanian Journal of Ophthalmology, Volume 59, Issue 3, July-September pp:
Romanian Journal of Ophthalmology, Volume 59, Issue 3, July-September 2015. pp:177-183 CASE REPORT A RARER FORM OF ANGLE-CLOSURE GLAUCOMA - DIAGNOSIS AND TREATMENT Zemba Mihail*,**, Stamate Alina-Cristina*,
More informationINTRODUCTION J. DAWCZYNSKI, E. KOENIGSDOERFFER, R. AUGSTEN, J. STROBEL. Department of Ophthalmology, University Hospital Jena, Jena - Germany
European Journal of Ophthalmology / Vol. 17 no. 3, 2007 / pp. 363-367 Anterior segment optical coherence tomography for evaluation of changes in anterior chamber angle and depth after intraocular lens
More informationGonioscopy and Slit Lamp Exam for the Glaucoma Suspect. Disclosure GONIOSCOPY: Gonioscopy Why?? What should I look for? GONIOSCOPY
Gonioscopy and Slit Lamp Exam for the Glaucoma Suspect Disclosure Michael Chaglasian has the following disclosures:» 1. Advisory Board: Alcon, Allergan, Bausch+Lomb, Carl Zeiss Meditec, Merck, Sucampo»
More informationChronicity. Narrow Minded. Course Outline. Acute angle closure. Subacute angle closure. Classification of Angle Closure 5/19/2014
Chronicity Narrow Minded The management of narrow angles in the optometric practice Acute Subacute Chronic Aaron McNulty, OD, FAAO Course Outline Classification of Angle Closure Evaluation of narrow angles
More informationEfficacy of latanoprost in management of chronic angle closure glaucoma. Kumar S 1, Malik A 2 Singh M 3, Sood S 4. Abstract
Original article Efficacy of latanoprost in management of chronic angle closure glaucoma Kumar S 1, Malik A 2 Singh M 3, Sood S 4 1 Associate Professor, 2 Assistant Professor, 4 Professor, Department of
More informationIncreased iris thickness and association with primary angle closure glaucoma
1 Singapore Eye Research Institute and Singapore National Eye Center, Singapore 2 Department of Ophthalmology, Beijing Shijitan Hospital, Beijing, China 3 State Key Laboratory of Ophthalmology, Zhongshan
More informationSAFE, PERMANENT EYE-COLOR CHANGE
SAFE, PERMANENT EYE-COLOR CHANGE Prepared by Gregg Homer JSD (PhD) February 1, 2012 THE PIGMENTARY GLAUCOMA ISSUE Glaucoma Defined Glaucoma is currently defined as a disturbance of the structural or functional
More informationUltrasound Biomicroscopic Changes of the Angle after Laser Iridotomy and Primary Trabeculectomy in Primary Angle Closure Glaucoma Patients
Med. J. Cairo Univ., Vol. 79, No. 2, December: 113-118, 2011 www.medicaljournalofcairouniversity.com Ultrasound Biomicroscopic Changes of the Angle after Laser Iridotomy and Primary Trabeculectomy in Primary
More informationStructural changes of the anterior chamber following cataract surgery during infancy
Structural changes of the anterior chamber following cataract surgery during infancy Matthew Nguyen, Emory University Marla Shainberg, Emory University Allen Beck, Emory University Scott Lambert, Emory
More informationTraining Checking Vision Tonometry
Training 101-2 Checking Vision Tonometry Checking Vision The classic example of an eye chart is the Snellen eye chart, in general they show 11 rows of capital letters. The top row contains one letter (usually
More informationSTUDY OF EFFECTIVENESS OF LENS EXTRACTION AND PCIOL IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA Sudhakar Rao P 1, K. Revathy 2, T.
STUDY OF EFFECTIVENESS OF LENS EXTRACTION AND PCIOL IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA Sudhakar Rao P 1, K. Revathy 2, T. Sreevathsala 3 HOW TO CITE THIS ARTICLE: Sudhakar Rao P, K. Revathy,
More informationClassification and management of primary angle closure disease
Classification and management of primary angle closure disease B. Shantha and Rathini Lilian David Major Review Correspondence: B. Shantha, Director, Smt Jadhavbai Nathmal Singhvee Glaucoma Service, Sankara
More informationSELECTIVE LASER TRABECULOPLASTY VS MICROPULSE LASER TRABECULOPLASTY FOR THE TREATMENT OF OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
SELECTIVE LASER TRABECULOPLASTY VS MICROPULSE LASER TRABECULOPLASTY FOR THE TREATMENT OF OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION DR. MARCELA IRENE DE LEÓN DE LEÓN 1, DR. JOSÉ FRANCISCO ORTEGA SANTANA
More information5/18/2014. Fundamentals of Gonioscopy Workshop Aaron McNulty, OD, FAAO Walt Whitley, OD, MBA, FAAO
1 Fundamentals of Gonioscopy Workshop Aaron McNulty, OD, FAAO Walt Whitley, OD, MBA, FAAO 2 3 4 5 6 Optometry s Meeting 2014 The Most Valuable Glaucoma Tool Glaucoma Diagnosis Gonioscopy Central corneal
More informationGlaucoma Glaucoma is a complication which has only recently been confirmed as a feature of
1.2.4 OPHTHALMOLOGICAL ABNORMALITIES Ocular abnormalities are well documented in patients with NPS 6 62 81 95. 1.2.4.1 Glaucoma Glaucoma is a complication which has only recently been confirmed as a feature
More informationDownloaded from:
Philippin, H; Shah, P; Burton, M (2012) The next step: Detailed assessment of an adult glaucoma patient. Community eye health / International Centre for Eye Health, 25 (79-80). pp. 50-53. ISSN 0953-6833
More informationUltrasound Biomicroscopy Dark Room Provocative Testing: A Quantitative Method for Estimating Anterior Chamber Angle Width
Ultrasound Biomicroscopy Dark Room Provocative Testing: A Quantitative Method for Estimating Anterior Chamber Angle Width Hiroshi Ishikawa,* Koji Esaki,* Jeffrey M. Liebmann, Yukitaka Uji* and Robert Ritch
More informationMessages From the Advanced Glaucoma Intervention Study
Landmark Studies Section editor: Ronald L. Fellman, MD Take-Home Messages From the Advanced Glaucoma Intervention Study By Leon W. Herndon, MD, and Daniel B. Moore, MD I tasked Leon W. Herndon, MD, and
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Pachymetry Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Pachymetry Professional Institutional Original Effective Date: March 11, 2004 Original Effective
More informationFACTORS INFLUENCING CATARACT FORMATION AFTER ND:YAG LASER PERIPHERAL IRIDOTOMY
FACTORS INFLUENCING CATARACT FORMATION AFTER ND:YAG LASER PERIPHERAL IRIDOTOMY BY James C. Bobrow MD* ABSTRACT Purpose: The benign nature of Nd:YAG laser peripheral iridotomy (LPI) has recently been questioned
More informationeffect of previous argon laser trabeculoplasty
Graefe s Arch Clin Exp Ophthalmol (2006) 244: 1073 1076 CLINICAL INVESTIGATION DOI 10.1007/s00417-005-0198-x Esther Arranz-Marquez Miguel A. Teus Effect of previous argon laser trabeculoplasty on the ocular
More informationWritten by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34
angle closure glaucoma A type of glaucoma caused by a sudden and severe rise in eye pressure. Occurs when the pupil enlarges too much or too quickly, and the outer edge of the iris blocks the eye s drainage
More informationGLAUCOMA SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES
SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN GUIDELINES Introduction These are summary benchmarks for the Academy s Preferred Practice Pattern (PPP) guidelines. The Preferred Practice Pattern series
More informationManagement of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015
Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015 Jimmy Lai Clinical Professor Department of Ophthalmology The University of Hong Kong 1 Primary Angle Closure Glaucoma PACG
More information9/25/2017 CASE. 67 years old On 2 topical meds since 3 years. Rx: +3.0 RE LE
CASE 67 years old On 2 topical meds since 3 years Rx: +3.0 /-0.5@65 RE +2.5/-0.5@115 LE IOP : 17 RE 19 LE CD: 0.5 RE 0.6 LE 1 67 years old On 2 topical meds since 3 years Rx: +3.0 /-0.5@65 RE +2.5/-0.5@115
More informationRomanian Journal of Ophthalmology, Volume 59, Issue 3, July-September pp:
Romanian Journal of Ophthalmology, Volume 59, Issue 3, July-September 2015. pp:148-153 GENERAL ARTICLE SELECTIVE LASER TRABECULOPLASTY SHORT TERM EFFICACY AND SAFETY PROFILE IN OPEN ANGLE GLAUCOMA OR OCULAR
More informationCorrelation between presence of primary irisand cilliary body cysts and intraocular pressure
European Review for Medical and Pharmacological Sciences 2017; 21: 3985-3989 Correlation between presence of primary irisand cilliary body cysts and intraocular pressure R. ZHU, L. CHENG, D.-M. WANG Institute
More informationLong Term Efficacy of Repeat Treatment with SLT: Seven Years Follow up
Long Term Efficacy of Repeat Treatment with SLT: Seven Years Follow up Lawrence F. Jindra, MD Columbia University Winthrop University Hospital Disclosure Speaker has independently conducted and financed
More informationFluctuation of Intraocular Pressure and Glaucoma Progression in the Early Manifest Glaucoma Trial
Fluctuation of Intraocular Pressure and Glaucoma Progression in the Early Manifest Glaucoma Trial Boel Bengtsson, PhD, 1 M. Cristina Leske, MD, MPH, 2 Leslie Hyman, PhD, 2 Anders Heijl, MD, PhD, 1 Early
More informationGlaucoma and Ocular Hypertension in Pseudoexfoliation Syndrome
Original Article Glaucoma and Ocular Hypertension in Pseudoexfoliation Syndrome Azfar Ahmed Mirza, Noor Bakht Nizamani, Mariya Nazish Memon, Sajjad Ali Surhio, Khalid I. Talpur Pak J Ophthalmol 2015, Vol.
More informationRoutine OCT and UBM of the anterior segment
Reprinted from No. 160 december 2012 Volume 17 Routine OCT and UBM of the anterior segment Michel Puech ISSN : 1274-5243 R e p r i n t e d w i t h t h e s u p p o r t o f t h e L a b o r a t o r y Q u
More informationPre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study
Nesaratnam et al. BMC Ophthalmology (2015) 15:17 DOI 10.1186/s12886-015-0007-1 RESEARCH ARTICLE Open Access Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective
More informationIntraocular pressure changes after clear corneal phacoemulsification in nonglaucomatous pseudoexfoliation syndrome
European Journal of Ophthalmology / Vol. 18 no. 1, 2008 / pp. 77-81 Intraocular pressure changes after clear corneal phacoemulsification in nonglaucomatous pseudoexfoliation syndrome D.J. CIMETTA 1, A.C.
More informationAuthor s Affiliation. Original Article
Original Article Comparison Between 0.5 Timolol Maleate And 0.2 Brimonidine Tartrate In Controlling Increase In Intraocular Pressure After Neodymium: Yttrium-Aluminium-Garnet Laser Iridotomy Author s Affiliation
More informationMacular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
Med. J. Cairo Univ., Vol. 83, No. 2, September: 67-72, 2015 www.medicaljournalofcairouniversity.net Macular Ganglion Cell Complex Measurement Using Spectral Domain Optical Coherence Tomography in Glaucoma
More informationRetrospective analysis of risk factors for late presentation of chronic glaucoma
24 Glaxo Department of Ophthalmic Epidemiology, Moorfields Eye Hospital, City Road, London EC1V 2PD S Fraser C Bunce R Wormald Correspondence to: Mr S G Fraser. Accepted for publication 31 July 1998 Retrospective
More informationOcular Hypotensive Efficacy of Netarsudil Ophthalmic Solution 0.02% Over a 24-Hour Period: A Pilot Study
Ocular Hypotensive Efficacy of Netarsudil Ophthalmic Solution 0.02% Over a 24-Hour Period: A Pilot Study James H. Peace, M.D. 1, Casey K. Kopczynski, Ph.D. 2, and Theresa Heah, M.D. 2 1 Inglewood, CA 2
More informationSpontaneous Intraocular Pressure Reduction in Normal-Tension Glaucoma and Associated Clinical Factors
CLINICAL INVESTIGATIONS Spontaneous Intraocular Pressure Reduction in Normal-Tension Glaucoma and Associated Clinical Factors Akihiro Oguri, Tetsuya Yamamoto and Yoshiaki Kitazawa Department of Ophthalmology,
More informationMEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND PACHYMETRY. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: CORNEAL ULTRASOUND,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationGlaucoma. How is Glaucoma Diagnosed? Glaucoma Testing
Glaucoma How is Glaucoma Diagnosed? Glaucoma Testing There is no single test for glaucoma. The diagnosis is made by evaluating the patient from a number of perspectives, using specialized instruments.
More informationGoals. Glaucoma PARA PEARL TO DO. Vision Loss with Glaucoma
Glaucoma Janet R. Fett, OD Drs. Kincaid, Fett and Tharp So Sioux City, NE eyewear21@hotmail.com Goals Understand Glaucoma Disease process Understand how your data (objective and subjective) assists in
More informationMorphological Study of Corneal Endothelium and Corneal Thickness in Pseudoexfoliation Syndrome
LABORATORY INVESTIGATIONS Morphological Study of Corneal Endothelium and Corneal Thickness in Pseudoexfoliation Syndrome Kenji Inoue*,, Kazuko Okugawa*,, Tetsuro Oshika and Shiro Amano *Department of Ophthalmology,
More informationNoel de Jesus Atienza, MD, MSc and Joseph Anthony Tumbocon, MD
Original Article Philippine Journal of OPHTHALMOLOGY Diagnostic Accuracy of the Optical Coherence Tomography in Assessing Glaucoma Among Filipinos. Part 1: Categorical Outcomes Based on a Normative Database
More informationSecondary open-angle glaucoma
Secondary open-angle glaucoma Kathy Hondeghem ZNA Middelheim MaNaMa 12/10/13 Definition Open anterior chamber angle (at least 270 ) Trabecular meshwork (and thus aqueous humor outflow) is occluded by a
More informationClinical decision making based on data from GDx: One year observations
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2002 Clinical decision making based on data from GDx: One year observations James C. Bobrow Washington University
More informationSelective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial
718 University Of Ottawa Eye Institute, Ottawa Hospital, Ottawa, Ontario, Canada K F Damji K C Shah W J Rock H S Bains W G Hodge Correspondence to: Dr Karim F Damji, University Of Ottawa Eye Institute,
More informationClosed Angle Glaucoma Or Narrow Angle Glaucoma. What s is a closed angle type of glaucoma,
Closed Angle Glaucoma Or Narrow Angle Glaucoma What s is a closed angle type of glaucoma, This is where the iris is found to be blocking the drainage of the eye through the trabecular meshwork. The eye
More informationClinical and Anterior Segment Anatomical Features in Primary Angle Closure Subgroups Based on Configurations of Iris Root Insertion
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2016;30(3):206-213 http://dx.doi.org/10.3341/kjo.2016.30.3.206 Original Article Clinical and Anterior Segment Anatomical Features in Primary Angle
More informationCollaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012
Collaboration in the care of glaucoma patients and glaucoma suspects Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Goals of Collaboration Patient-centred and evidence based approach Timely access
More informationA LITTLE ANATOMY. three layers of eye: 1. outer: corneosclera. 2. middle - uvea. anterior - iris,ciliary body. posterior - choroid
GLAUCOMA A LITTLE ANATOMY three layers of eye: 1. outer: corneosclera 2. middle - uvea anterior - iris,ciliary body posterior - choroid connection at the pars plana between post and ant uvea 3. retina
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Conversion of Ocular Hypertensives into Glaucoma: A Retrospective Study Aditi Singh 1, Shibi
More informationUBM and glaucoma: diagnosis and follow-up of plateau iris. M. Puech
ophtalmologiques UBM and glaucoma: diagnosis and follow-up of plateau iris M. Puech Extrait du mensuel Réalités Ophtalmologiques N 204 Juin 2013 Cahier 1 Editeur : Performances Médicales 91, avenue de
More informationAnterior segment imaging
Article Date: 11/1/2016 Anterior segment imaging AS OCT vs. UBM vs. endoscope; case based approaches BY BENJAMIN BERT, MD, FACS AND BRIAN FRANCIS, MD, MS Currently, numerous imaging modalities are available
More informationAqueous Humor Levels of Soluble Fas and Fas-ligand in Patients with Primary Open Angle and Pseudoexfoliation
ISSN 1735-1383 Iran. J. Immunol. December 2007, 4 (4), 215 219 Mohammad Reza Razeghinejad, Eskandar Kamali-Sarvestani Aqueous Humor Levels of Soluble Fas and Fas-ligand in Patients with Primary Open Angle
More informationTHE CURRENT TREATMENT OF GLAUCOMA IS DIrected
Three-Year Follow-up of the Tube Versus Trabeculectomy Study STEVEN J. GEDDE, JOYCE C. SCHIFFMAN, WILLIAM J. FEUER, LEON W. HERNDON, JAMES D. BRANDT, AND DONALD L. BUDENZ, ON BEHALF OF THE TUBE VERSUS
More informationchamber pigment in the anterior L beration of iris phenylephrine hydrochloride solution. After instillation of io per cent.
Brit.. Ophthal. (I 97 I) 55, 544 L beration of iris chamber After instillation of io per cent. hydrochloride solution J. L. AGGARWAL AND B. BEVERIDGE Wolverhampton and Midland Counties Eye Infirmary pigment
More informationLong-term outcome after cataract extraction in patients with an attack of acute phacomorphic angle closure
ORIGINAL ARTICLE Long-term outcome after cataract extraction in patients with an attack of acute phacomorphic angle closure Jimmy S. M. Lai, 1 FRCS, FRCOphth, FHKAM (Ophthalmology), M.Med (Ophthalmology),
More informationThe Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Cataract November 2016 Association of Health Professions in Ophthalmology General basic competences
More informationReverse pupillary block after implantation of a scleral-sutured posterior chamber intraocular lens: a retrospective, open study
Bang et al. BMC Ophthalmology (2017) 17:35 DOI 10.1186/s12886-017-0427-1 RESEARCH ARTICLE Open Access Reverse pupillary block after implantation of a scleral-sutured posterior chamber intraocular lens:
More informationSTANDARD AUTOMATED PERIMETRY IS A GENERALLY
Comparison of Long-term Variability for Standard and Short-wavelength Automated Perimetry in Stable Glaucoma Patients EYTAN Z. BLUMENTHAL, MD, PAMELA A. SAMPLE, PHD, LINDA ZANGWILL, PHD, ALEXANDER C. LEE,
More informationCurriculum for the Glaucoma EBO EGS Subspecialty exam and the FEBOD Glaucoma diploma
Curriculum for the Glaucoma EBO EGS Subspecialty exam and the FEBOD Glaucoma diploma Introduction This document defines the requirements for the subspecialty exam in Glaucoma, organized by the EBO (European
More informationPseudophakic angle-closure from a Soemmering ring
Suwan et al. BMC Ophthalmology (2016) 16:91 DOI 10.1186/s12886-016-0257-6 CASE REPORT Open Access Pseudophakic angle-closure from a Soemmering ring Yanin Suwan *, Bayasgalan Purevdorj, Chaiwat Teekhasaenee,
More informationClinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome
Hindawi Publishing Corporation Journal of Ophthalmology Volume 215, Article ID 62372, 5 pages http://dx.doi.org/1.1155/215/62372 Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic
More informationInaccuracy of Intraocular Lens Power Prediction for Cataract Surgery in Angle-Closure Glaucoma
Original Article DOI 10.3349/ymj.2009.50.2.206 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 50(2):206-210, 2009 Inaccuracy of Intraocular Lens Power Prediction for Cataract Surgery in Angle-Closure
More informationGlaucoma. Cornea. Iris
Glaucoma Introduction Glaucoma is a group of eye diseases that can lead to blindness if not treated. Openangle glaucoma, the most common form of glaucoma, affects about 3 million Americans. Half of those
More informationINFANTILE NEPHROPATHIC cystinosis
CLINICAL SCIENCES Ultrasound Biomicroscopy of the Eye in Cystinosis Nils Mungan, MD, FRCSC; Ken K. Nischal, FRCOphth; Elise Héon, MD, FRCSC; Leslie MacKeen, CRA; J. Williamson Balfe, MD, FRCPC; Alex V.
More informationCorporate Medical Policy
Corporate Medical Policy Optical Coherence Tomography (OCT) Anterior Segment of the Eye File Name: Origination: Last CAP Review: Next CAP Review: Last Review: optical_coherence_tomography_(oct)_anterior_segment_of_the_eye
More informationLong-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma
(2007) 21, 936 940 & 2007 Nature Publishing Group All rights reserved 0950-222X/07 $30.00 www.nature.com/eye CLINICAL STUDY Long-term efficacy and visual acuity following transscleral diode laser photocoagulation
More informationAssessment of Effects of Different Mydriatics on Choroidal Thickness by Examining Anterior Chamber Parameters
Open Access World Journal of Ophthalmology & Vision Research Research Article Copyright All rights are reserved by Fahmy RM Assessment of Effects of Different Mydriatics on Choroidal Thickness by Examining
More informationPrognostic Factors for the Success of Laser Iridotomy for Acute Primary Angle Closure Glaucoma
Korean Journal of Ophthalmology 2009;23:286-290 ISSN : 1011-8942 DOI : 10.3341/kjo.2009.23.4.286 Prognostic Factors for the Success of Laser Iridotomy for Acute Primary Angle Closure Glaucoma Jong Wook
More informationStudy of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma
Study of Retinal Nerve Fiber Layer Thickness Within Normal Hemivisual Field in Primary Open-Angle Glaucoma and Normal-Tension Glaucoma Chiharu Matsumoto, Shiroaki Shirato, Mai Haneda, Hiroko Yamashiro
More informationThe Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Glaucoma November 2016 Association of Health Professions in Ophthalmology General basic competences
More informationPrevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
original clinical study Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India Tirupati Nath, MS, FMRF,* Subham
More informationCLINICAL SCIENCES. Angle-closure Glaucoma Associated With Occult Annular Ciliary Body Detachment
CLINICAL SCIENCES Angle-closure Glaucoma Associated With Occult Annular Ciliary Body Detachment Jeffrey M. Liebmann, MD; Robert N. Weinreb, MD; Robert Ritch, MD Objective: To evaluate the role of annular
More informationPlateau Iris Syndrome and Acute Angle Closure Glaucoma: A Teaching Case Report 1
Report 1 By: Theresa Zerilli, OD, FAAO, Tam Nguyen, OD, MS, FAAO, Christine L. Burke, OD, FAAO, and Jonathan R. Hamilton, OD, FAAO Background Primary angle closure glaucoma is characterized by apposition
More informationFive-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study
Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study Donald L Budenz, MD, MPH; Keith Barton, MD; Steven J Gedde, MD; William J Feuer, MS; Joyce Schiffman, MS; Vital P Costa, MD; David
More informationPrimary angle closure glaucoma (PACG) is one of the leading
Glaucoma Comparison of Anterior Segment Parameters Between the Acute Primary Angle Closure Eye and the Fellow Eye Jong Rak Lee, 1 Kyung Rim Sung, 1 and Seungbong Han 2 1 Department of Ophthalmology, University
More informationCitation BMC Ophthalmology, 2016, v. 16, article no. 64
Title Recurrent acute angle-closure attack due to plateau iris syndrome after cataract extraction with or without argon laser peripheral iridoplasty: a case report Author(s) Choy, NKB; Chan, JCH; Chien,
More informationPopulations Interventions Comparators Outcomes Individuals: Who are being evaluated for angleclosure
Protocol Optical Coherence Tomography of the Anterior Eye Segment (90318) Medical Benefit Effective Date: 07/01/14 Next Review Date: 05/18 Preauthorization No Review Dates: 07/11, 07/12, 07/13, 05/14,
More informationRole of Central Corneal Thickness in Circadian Intraocular Pressure Fluctuations among Patients with Primary Open Angle Glaucoma
Role of Central Corneal Thickness in Circadian Intraocular Pressure Fluctuations among Patients with Primary Open Angle Glaucoma Mohannad Albdour MD*, Karanjit Kooner MD, PHD** ABSTRACT Objectives: To
More informationTHE TRABECTOME IS A NOVEL SURGICAL DEVICE USED
Delayed-Onset Symptomatic Hyphema After Ab Interno Trabeculotomy Surgery YACHNA AHUJA, MEHRDAD MALIHI, AND ARTHUR J. SIT PURPOSE: To describe patients who have experienced delayed-onset hyphema after ab
More informationThe Uniocular Drug Trial and Second-Eye Response to Glaucoma Medications
The Uniocular Drug Trial and Second-Eye Response to Glaucoma Medications Tony Realini, MD, 1 Robert D. Fechtner, MD, 2 Sean-Paul Atreides, MD, 3 Stephen Gollance, MD 2 Purpose: To determine if the intraocular
More informationClinical Profile and Demographics of Glaucoma Patients Managed in a Philippine Tertiary Hospital
Original Article Philippine Journal of OPHTHALMOLOGY Clinical Profile and Demographics of Patients Managed in a Philippine Tertiary Hospital Jose Ma. Martinez, MD 1,2 and Mark Angelo B. Hosaka, MD 1 Eye
More informationNeovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion
Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Man-Seong Seo,* Jae-Moon Woo* and Jeong-Jin Seo *Department of Ophthalmology, Chonnam
More informationGlaucoma What You Should Know
Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads
More informationUltrasound Biomicroscopy Noel Moniz, MS L.F. Hospital and Reserach Centre, Angamaly
Ultrasound Biomicroscopy Noel Moniz, MS L.F. Hospital and Reserach Centre, Angamaly F O C U S The ultrasound biomicroscope works on the principle of an ultrasound but at a higher frequency. The normal
More informationTargeting Intraocular Pressure in Glaucoma: a Teaching Case Report 1
Targeting Intraocular Pressure in Glaucoma: a Teaching Case Report 1 By: Andrew Kemp, OD, Marcus Gonzales, OD, FAAO, Joe DeLoach, OD, FAAO, and Zanna Kruoch, OD FAAO Background Glaucoma is a range of conditions
More informationPRESENTED By DR. FAISAL ALMOBARAK, MD
PRESENTED By DR. FAISAL ALMOBARAK, MD Early FAC associated with hypotony is an important complication after glaucoma filtering procedures, especially trabeculectomy. The reported incidence after trabeculectomy
More informationClinical Study Age and Positional Effect on the Anterior Chamber Angle: Assessment by Ultrasound Biomicroscopy
Hindawi Publishing Corporation ISRN Ophthalmology Volume 2013, Article ID 706201, 5 pages http://dx.doi.org/10.1155/2013/706201 Clinical Study Age and Positional Effect on the Anterior Chamber Angle: Assessment
More informationScience & Technologies
STANDARD COMPUTERIZED PERIMETRY IN FUNCTION OF DIAGNOSTIC GLAUCOMA Iljaz Ismaili, 1 Gazepov Strahil, 2, Goshevska Dashtevska Emilija 1 1 University Eye Clinic,Skopje 2 Clinical Hospital, Shtip Abstract
More informationScanning Laser Polarimetry in Patients with Acute Attack of Primary Angle Closure
Scanning Laser Polarimetry in Patients with Acute Attack of Primary Angle Closure Jimmy S. M. Lai*, Clement C. Y. Tham, Jonathan C. H. Chan*, Nelson K. F. Yip, Wilson W. T. Tang, Patrick S. H. Li*, Jane
More information